Associated Papers
Predicting the Damaging Potential of Uncharacterized KCNQ1 and KCNE1 Variants.
Tarnovskaya SI et al.
International Journal of Molecular Sciences, 2025
40724807 (PubMed )
Supplement: ijms-26-06561-s001.zip › ijms-3705358_SupplementaryTable1.xlsx › SupplementaryTable1_upd
Open channel block of Kv1.5 channels by HMQ1611.
Dong C et al.
Frontiers in Pharmacology, 2022
Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
Ding WG et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2019
Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.
Kojima A et al.
Journal of Cardiovascular Pharmacology, 2018
Regulation of human cardiac Kv1.5 channels by extracellular acidification.
Wang S et al.
Pflugers Archiv : European Journal of Physiology, 2016
High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
Karczewski J et al.
Biochemical Pharmacology, 2009
The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels.
Eldstrom J et al.
Molecular Pharmacology, 2007
Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
Decher N et al.
Molecular Pharmacology, 2005
Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
Decher N et al.
The Journal of Biological Chemistry, 2004
Select a paper to view details